Page 119 - Journal of Special Operations Medicine - Fall 2015
P. 119

RABIES VACCINES AND IMMUNOGLOBULIN AVAILABLE IN THE UNITED STATES
              Type                         Name                         Route                       Indications
              Human Diploid Cell Vaccine   Imovax  Rabies            Intramuscular                Preexposure or
                                             ®
              (HDCV)                                                                               Postexposure
              Purified Chick Embryo Cell   RabAvert ®                Intramuscular                Preexposure or
              Vaccine (PCEC)                                                                       Postexposure
              Human Rabies Immune         Imogam         Local infusion at wound site, with additional   Postexposure
                                                ®
              Globulin                   Rabies-HT     amount intramuscular at site distant from vaccine
              Human Rabies Immune      HyperRab  S/D     Local infusion at wound site, with additional   Postexposure
                                               ™
              Globulin                                 amount intramuscular at site distant from vaccine
                                   POSTEXPOSURE PROPHYLAXIS FOR NON-IMMUNIZED INDIVIDUALS
              Treatment                                                 Regimen
                                       All postexposure prophylaxis should begin with immediate thorough cleansing of all wounds
              Wound cleansing          with soap and water. If available, a virucidal agent such as povidine-iodine solution should be
                                       used to irrigate the wounds.
                                       If possible, the full dose should be infiltrated around any wound(s) and any remaining volume
                                       should be administered IM at an anatomical site distant from vaccine administration. Also,
              RIG
                                       RIG should not be administered in the same syringe as vaccine. Because RIG might partially
                                       suppress active production of antibody, no more than the recommended dose should be given.
              Vaccine                  HDCV or PCECV 1.0 mL, IM (deltoid area ), one each on days 0 , 3, 7, and 14.
                                POSTEXPOSURE PROPHYLAXIS FOR PREVIOUSLY IMMUNIZED INDIVIDUALS
              Treatment                                                 Regimen
                                       All postexposure prophylaxis should begin with immediate thorough cleansing of all wounds
              Wound cleansing          with soap and water. If available, a virucidal agent such as povidine-iodine solution should be
                                       used to irrigate the wounds.
              RIG                      RIG should not be administered.
              Vaccine                  HDCV or PCECV 1.0 mL, IM (deltoid area), one each on days 0 and 3.
              Source: Reprinted from the Centers for Disease Control and Prevention. http://www.cdc.gov/rabies/medical_care/index.html.

              Disclaimer                                         Medical College of Wisconsin. Milwaukee protocol, version 4.0 (up-
                                                                    dated 9/13/2012).  http://www.mcw.edu/FileLibrary/Groups
              The views expressed in this publication are those of the   /PedsInfectiousDiseases/Rabies/Milwaukee_protocol_v4
              author and do not reflect the official policy or position   _20913.pdf.
              of the Department of the Army, Department of Defense,   Rupprecht CE, Briggs D, Brown CM, et al. Use of a reduced
              or the US Government.                                 (4-dose) vaccine schedule for postexposure prophylaxis to
                                                                    prevent human rabies: recommendations of the Advisory
                                                                    Committee on Immunization Practices.  MMWR. 2010;59
              Disclosure                                            (RR02):1–9.
                                                                 US Centers for Disease Control and Prevention. Rabies.  http://
              The author has nothing to disclose.                   www.cdc.gov/rabies/.
                                                                 World Health Organization. Rabies. http://www.who.int/rabies/en/.

              Bibliography
              Hanlon CA, Schlim DR. Ch. 3: Infectious diseases related to
                 travel. Rabies. In: CDC Health Information for International   COL Burnett is currently the Area-Support Group-Kuwait
                 Travel. 2015. http://wwwnc.cdc.gov/travel/yellowbook/2014   Command Surgeon and is Board-Certified in Pediatrics and
                 /chapter-3-infectious-diseases-related-to-travel/rabies.  Pediatric Infectious Diseases. He has served overseas in  Korea,
              Immunization Action Coalition. Disease and Vaccines. http://www   Germany, Kosovo, Iraq, Afghanistan, Kuwait, and as the
                 .immunize.org/rabies/.                          JSOTF-P Surgeon in the Philippines. He is a graduate of the
              Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies pre-  University of Wisconsin-Madison and the Medical College of
                 vention – United States, 2008. Recommendations of the Ad-  Wisconsin. E-mail: mark.w.burnett.mil@mail.mil.
                 visory Committee on Immunization Practices. MMWR 2008;
                 57(RR03):1–26, 28.








              Rabies: 2015 Update                                                                            107
   114   115   116   117   118   119   120   121   122   123   124